The firm attributed the increase in part to life sciences and diagnostics revenue that was better than expected.
The company is the first commercial lab in the US to agree to implement the system, which it will begin using in the first quarter of the year.
The test detects Borrelia bacteria directly from skin interstitial fluid samples from people with signs of tick bites or erythema migrans.
The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
The firm attributed the increase in part to life sciences and diagnostics revenue that was better than expected.
Meridian Bioscience subsidiary Magellan Diagnostics was previously ordered to pay $42 million for selling the tests.
The researchers studied volatile organic compounds in the breath and determined some may have diagnostic utility for issues in the gut microbiome, as well as for asthma.
The researchers studied volatile organic compounds in the breath and determined some may have diagnostic utility for issues in the gut microbiome, as well as for asthma.
The stock split will reduce the company's outstanding common stock from approximately 2.8 million shares to about 709,000 shares.
The project aims to develop a library of T cells with specific receptors, ultimately contributing to development of a blood test for immunological fingerprinting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results